| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |